India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator says

India's drug regulator took action against 90% of inspected high-risk pharmaceutical facilities.

The crackdown follows Indian-made cough syrups linked to child deaths in Gambia, Uzbekistan, and Cameroon.

India is known as the 'pharmacy of the world' and aims to strengthen quality standards.

The regulator's actions are part of broader efforts to improve drug manufacturing safety.